Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke.


Journal

Journal of neurology, neurosurgery, and psychiatry
ISSN: 1468-330X
Titre abrégé: J Neurol Neurosurg Psychiatry
Pays: England
ID NLM: 2985191R

Informations de publication

Date de publication:
08 2020
Historique:
received: 15 04 2020
accepted: 17 04 2020
pubmed: 2 5 2020
medline: 1 8 2020
entrez: 2 5 2020
Statut: ppublish

Résumé

Emergence of the novel corona virus (severe acute respiratory syndrome (SARS)-CoV-2) in December 2019 has led to the COVID-19 pandemic. The extent of COVID-19 involvement in the central nervous system is not well established, and the presence or the absence of SARS-CoV-2 particles in the cerebrospinal fluid (CSF) is a topic of debate. We present two patients with COVID-19 and concurrent neurological symptoms. Our first patient is a 31-year-old man who had flu-like symptoms due to COVID-19 and later developed an acute-onset severe headache and loss of consciousness and was diagnosed with a Hunt and Hess grade 3 subarachnoid haemorrhage from a ruptured aneurysm. Our second patient is a 62-year-old woman who had an ischaemic stroke with massive haemorrhagic conversion requiring a decompressive hemicraniectomy. Both patients' CSF was repeatedly negative on real-time PCR analysis despite concurrent neurological disease. Our report shows that patients' CSF may be devoid of viral particles even when they test positive for COVID-19 on a nasal swab. Whether SARS-CoV-2 is present in CSF may depend on the systemic disease severity and the degree of the virus' nervous tissue tropism and should be examined in future studies.

Sections du résumé

BACKGROUND
Emergence of the novel corona virus (severe acute respiratory syndrome (SARS)-CoV-2) in December 2019 has led to the COVID-19 pandemic. The extent of COVID-19 involvement in the central nervous system is not well established, and the presence or the absence of SARS-CoV-2 particles in the cerebrospinal fluid (CSF) is a topic of debate.
CASE DESCRIPTION
We present two patients with COVID-19 and concurrent neurological symptoms. Our first patient is a 31-year-old man who had flu-like symptoms due to COVID-19 and later developed an acute-onset severe headache and loss of consciousness and was diagnosed with a Hunt and Hess grade 3 subarachnoid haemorrhage from a ruptured aneurysm. Our second patient is a 62-year-old woman who had an ischaemic stroke with massive haemorrhagic conversion requiring a decompressive hemicraniectomy. Both patients' CSF was repeatedly negative on real-time PCR analysis despite concurrent neurological disease.
CONCLUSION
Our report shows that patients' CSF may be devoid of viral particles even when they test positive for COVID-19 on a nasal swab. Whether SARS-CoV-2 is present in CSF may depend on the systemic disease severity and the degree of the virus' nervous tissue tropism and should be examined in future studies.

Identifiants

pubmed: 32354770
pii: jnnp-2020-323522
doi: 10.1136/jnnp-2020-323522
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

846-848

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Fadi Al Saiegh (F)

Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Ritam Ghosh (R)

Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Adam Leibold (A)

Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Michael B Avery (MB)

Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Richard F Schmidt (RF)

Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Thana Theofanis (T)

Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Nikolaos Mouchtouris (N)

Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Lucas Philipp (L)

Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Stephen C Peiper (SC)

Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States.

Zi-Xuan Wang (ZX)

Surgery & Pathology, Molecular & Genomic Pathology Laboratory, Thomas Jefferson University, Philadelphia, Pennsylvania, United States.

Fred Rincon (F)

Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Stavropoula I Tjoumakaris (SI)

Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Pascal Jabbour (P)

Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Robert H Rosenwasser (RH)

Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

M Reid Gooch (MR)

Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA reid.gooch@jefferson.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH